The Peptide Craze Ground Truths FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of Updated 2026 FDA Category 2 peptide list As the science and regulations continue to develop, it's important to work with providers who stay informed and prioritize safe, medically guided protocols. At The Pharmacology of Longevity: Peptide Edition (Part 1) FDA Moves to Reevaluate Several Peptides American Med Spa Association